We tried to shed light on the expression of PD1 and CD138+ microparticles in MM and their possible interplay as a mechanism of resistance to standardized treatments by proteasome inhibitors and immunomodulatory drugs, in addition, find their associations with other prognostic factors of symptomatic MM. This evidence concerns the gene RPL17 and Miyoshi myopathy.